Literature DB >> 31445496

Aqueous Extract of Whitmania Pigra Whitman Alleviates Thrombus Burden Via Sirtuin 1/NF-κB Pathway.

Xiao-Lan Yao1, Han Liu1, Peng Li1, Wen-Pei Chen1, Shi-Xia Guan1, Yang Chen1, Yi-Na Wu1, Bao-Qin Lin2.   

Abstract

BACKGROUND: Whitmania pigra Whitman (W pigra), a traditional Chinese medicine, has functions of breaking stagnant and eliminating blood stasis. The aim of this study was to investigate the underlying mechanism of W pigra against deep vein thrombosis (DVT).
METHODS: A rat model of DVT induced by inferior vena cava stenosis was successfully established. Rats were administered vehicle (saline solution, p.o.), three doses of W pigra aqueous extract (34.7, 104.2, or 312.5 mg crude W pigra/kg, p.o.), heparin (200 U/kg, i.v.), or clopidogrel (25 mg/kg, p.o.) once daily for 2 d. Thrombus weight and histopathological changes were examined. Blood samples were collected to determine blood cell counts, blood viscosity, blood coagulation, blood fibrinolysis, serum levels of interleukin-1β, and tumor necrosis factor-α. Protein expressions of Sirtuin1 (SIRT1), acetylated p65 (Ace-p65), and phosphorylated p65 (p-p65) were determined by Western blot. Furthermore, SIRT1-specific inhibitor EX527 was applied to confirm the role of SIRT1 in the antithrombotic effect of W pigra.
RESULTS: W pigra significantly decreased thrombus weight. W pigra had no effects on blood cell counts, whole blood viscosity, blood coagulation, blood fibrinolysis. However, it reduced tissue factor protein expression in the vein wall and thrombus. Moreover, it sharply increased SIRT1 protein expression and decreased leukocytes recruitment in the thrombus and vein wall, serum levels of interleukin-1β and tumor necrosis factor-α, and protein expressions of Ace-p65 and p-p65. Furthermore, the antithrombotic effect of W pigra was significantly abolished by EX527.
CONCLUSIONS: Aqueous extract of W pigra effectively reduced DVT burden by inhibiting inflammation via SIRT1/nuclear factor-kappa B signaling pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep vein thrombosis; Inflammation; NF-κB; SIRT1; Whitmania pigra whitman

Mesh:

Substances:

Year:  2019        PMID: 31445496     DOI: 10.1016/j.jss.2019.07.094

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial.

Authors:  Bangjiang Fang; Wen Zhang; Xinxin Wu; Tingrong Huang; Huacheng Li; You Zheng; Jinhua Che; Shuting Sun; Chao Jiang; Shuang Zhou; Jun Feng
Journal:  Trials       Date:  2020-06-24       Impact factor: 2.279

Review 2.  The aging venous system: from varicosities to vascular cognitive impairment.

Authors:  Andrea Ágnes Molnár; György László Nádasy; Gabriella Dörnyei; Bernadett Bettina Patai; Jordan Delfavero; Gábor Áron Fülöp; Angelia C Kirkpatrick; Zoltán Ungvári; Béla Merkely
Journal:  Geroscience       Date:  2021-11-11       Impact factor: 7.713

3.  Traditional Chinese Medicine Shen-Yuan-Dan (SYD) Improves Hypoxia-Induced Cardiomyocyte Apoptosis in Neonatal Rats by Upregulating miR-24/Bim Pathway.

Authors:  Fuyong Chu; Xue Yan; Xingjiang Xiong; Mingxue Zhou; Yupei Tan; Yixuan Li; Wei Liu; Hongxu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-03       Impact factor: 2.629

4.  Zhilong Huoxue Tongyu Capsules Ameliorate Early Brain Inflammatory Injury Induced by Intracerebral Hemorrhage via Inhibition of Canonical NFкβ Signalling Pathway.

Authors:  Maryam Mazhar; Guoqiang Yang; Linshen Mao; Pan Liang; Ruizhi Tan; Li Wang; Houping Xu; Luyin Yang; Wei Ren; Sijin Yang
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

5.  Aqueous extract of Whitmania pigra Whitman ameliorates ferric chloride-induced venous thrombosis in rats via antioxidation.

Authors:  Peng Li; Bingqing Lin; Ping Tang; Yuxin Ye; Zhongrui Wu; Shuhua Gui; Yaxian Zhan; Wei Yang; Baoqin Lin
Journal:  J Thromb Thrombolysis       Date:  2020-11-17       Impact factor: 2.300

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.